1 | 1643368-58-4 | - | - | - | - | 2件: 53 53, 160 💬
|
2 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
3 | Active topical NS2 1% dermatologic cream | - | - | - | - | 1件: 160 160 💬
|
4 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件: 19 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
|
5 | ADX-629 | - | - | - | - | 1件: 160 160 💬
|
6 | ANTI-CD28DAB | - | - | - | - | 3件: 49 49, 53, 160 💬
|
7 | Apply veregen ® 10 % ON A randomized area and THE moisturizing cream OF THE other side | - | - | - | - | 1件: 160 160 💬
|
8 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 17件: 13 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
|
9 | ATR12-351 | - | - | - | - | 1件: 160 160 💬
|
10 | BCX17725 | - | - | - | - | 1件: 160 160 💬
|
11 | Bezafibrate | 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate
Bezafibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 8件: 20 20, 93, 94, 160, 296, 316, 324, 344 💬
|
12 | Bezalip retard | - | - | - | - | 1件: 160 160 💬
|
13 | BMS-188667 | - | - | - | - | 10件: 46 46, 49, 53, 65, 96, 97, 107, 160, 222, 271 💬
|
14 | BMS-931699 | 1件: Lulizumab pegol Lulizumab pegol | - | - | - | 3件: 49 49, 53, 160 💬
|
15 | BMS-986142 | 1件: BMS-986142 BMS-986142 | - | - | - | 3件: 46 46, 53, 160 💬
|
16 | BMS986142 | - | - | - | - | 3件: 46 46, 53, 160 💬
|
17 | BPR277 | - | - | - | - | 1件: 160 160 💬
|
18 | BPR277 ointment | - | - | - | - | 1件: 160 160 💬
|
19 | BTK inhibitor | - | - | - | - | 3件: 46 46, 53, 160 💬
|
20 | Cholesterol | 1件: Cholesterol Cholesterol | 1件: Cholesterol
Cholesterol
💬
| - | - | 5件: 19 19, 90, 160, 222, 310 💬
|
21 | CNT-02 | - | - | - | - | 1件: 160 160 💬
|
22 | Deucravacitinib | 1件: Deucravacitinib Deucravacitinib | 1件: Deucravacitinib
Deucravacitinib
💬
| 1件: TYK2 TYK2 💬
| 17件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | 9件: 36 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
|
23 | DS-2325A | 1件: DS-2325a DS-2325a | - | - | - | 1件: 160 160 💬
|
24 | Dupilumab | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 💬
|
25 | Dupilumab injection | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 💬
|
26 | Dupilumab prefilled syringe | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 💬
|
27 | Dupixent | 1件: Dupilumab Dupilumab | 1件: Dupilumab
Dupilumab
💬
| 1件: IL4R IL4R 💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 3件: 98 98, 160, 162 💬
|
28 | Epithelial sheet generated from transduced autologous keratinocytes using PCCL-INVO-SP | - | - | - | - | 1件: 160 160 💬
|
29 | Erlotinib | 1件: Erlotinib Erlotinib | 2件: Erlotinib hydrochloride
Erlotinib hydrochloride
,
Erlotinib
💬
| 1件: EGFR EGFR 💬
| 47件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬 | 2件: 94 94, 160 💬
|
30 | Fibrate treatment | - | - | - | - | 1件: 160 160 💬
|
31 | Hematopoetic stem cell transplantation | - | - | - | - | 6件: 19 19, 65, 121, 160, 308, 326 💬
|
32 | Humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 9件: 46 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
|
33 | Isotretinoin | 1件: Isotretinoin Isotretinoin | 1件: Isotretinoin
Isotretinoin
💬
| 2件: RARA RARA, RARB 💬
| 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 4件: 36 36, 39, 159, 160 💬
|
34 | Isotretinoina | - | - | - | - | 1件: 160 160 💬
|
35 | Ixekizumab | 1件: Ixekizumab Ixekizumab | 1件: Ixekizumab
Ixekizumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 36 36, 37, 46, 107, 160, 162, 269, 271 💬
|
36 | KB105 | 1件: KB105 KB105 | - | - | - | 1件: 160 160 💬
|
37 | L04ab04 | - | - | - | - | 5件: 46 46, 96, 107, 160, 271 💬
|
38 | Lipoxygenase inhibitor | - | - | - | - | 1件: 160 160 💬
|
39 | Lovastatin | 1件: Lovastatin Lovastatin | 1件: Lovastatin
Lovastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
|
40 | Monolaurin cream | 1件: Glyceryl laurate Glyceryl laurate | - | - | - | 1件: 160 160 💬
|
41 | ONE 20cm2/10cm2 autologous skin sheet graft | - | - | - | - | 1件: 160 160 💬
|
42 | Oral glucose tolerance test | - | - | - | - | 6件: 6 6, 13, 77, 160, 195, 299 💬
|
43 | Orencia | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 15件: 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
|
44 | Oxiconazole | 1件: Oxiconazole Oxiconazole | 2件: Oxiconazole nitrate
Oxiconazole nitrate
,
Oxiconazole
💬
| - | - | 1件: 160 160 💬
|
45 | Palliative care | - | - | - | - | 6件: 19 19, 65, 121, 160, 308, 326 💬
|
46 | PAT | - | - | - | - | 1件: 160 160 💬
|
47 | Pimecrolimus 1% cream | 1件: Pimecrolimus Pimecrolimus | 1件: Pimecrolimus
Pimecrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 160 160 💬
|
48 | QRX003, 4% lotion | - | - | - | - | 1件: 160 160 💬
|
49 | QRX003-2% lotion | - | - | - | - | 1件: 160 160 💬
|
50 | QRX003-4% lotion BID | - | - | - | - | 1件: 160 160 💬
|
51 | QRX003-4% lotion QAM | - | - | - | - | 1件: 160 160 💬
|
52 | Reproxalap | 1件: Reproxalap Reproxalap | 1件: Reproxalap
Reproxalap
💬
| - | - | 1件: 160 160 💬
|
53 | RVG 18388 | - | - | - | - | 1件: 160 160 💬
|
54 | SAR231893 | - | - | - | - | 2件: 51 51, 160 💬
|
55 | Secukinumab | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬
|
56 | Secukinumab injection | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 160 160 💬
|
57 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 19件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
|
58 | Spesolimab | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 5件: 37 37, 96, 97, 160, 269 💬
|
59 | Spesolimab - solution FOR infusion | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 160 160 💬
|
60 | Spesolimab - solution FOR injection | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 160 160 💬
|
61 | SXR1096 | - | - | - | - | 1件: 160 160 💬
|
62 | Symptomatic therapy | - | - | - | - | 1件: 160 160 💬
|
63 | TMB-001 | - | - | - | - | 1件: 160 160 💬
|
64 | Ustekinumab injection | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 160 160 💬
|
65 | Vehicle | - | - | - | - | 5件: 6 6, 36, 53, 160, 192 💬
|
66 | Vehicle OF ADX-102 topical dermal cream | - | - | - | - | 1件: 160 160 💬
|
67 | Zileuton | 1件: Zileuton Zileuton | 1件: Zileuton
Zileuton
💬
| 1件: ALOX5 ALOX5 💬
| 6件: Arachidonic acid metabolism Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬 | 3件: 85 85, 160, 164 💬
|
68 | Zyflo CR | 1件: Zileuton Zileuton | 1件: Zileuton
Zileuton
💬
| 1件: ALOX5 ALOX5 💬
| 6件: Arachidonic acid metabolism Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬 | 1件: 160 160 💬
|